NCT05913284View on ClinicalTrials.gov

Intravenous Methadone in Perioperative Acute and Chronic Management in Chinese Adult Cardiac Surgical Patients

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

February 1, 2026

Study Completion Date

April 1, 2026

Conditions
Pain, PostoperativePain, AcutePain, ChronicAnesthesia
Interventions
DRUG

Methadone

The drug will be prepared by study investigator and then handover to the anaesthesiologist which is blinded to the study. The syringe will be labelled as study drug and given on induction of anaesthesia as intravenous infusion over 30 minutes

DRUG

Morphine

The drug will be prepared by study investigator and then handover to the anaesthesiologist which is blinded to the study. The syringe will be labelled as study drug and given on induction of anaesthesia as intravenous infusion over 30 minutes

Trial Locations (1)

Unknown

Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT05913284 - Intravenous Methadone in Perioperative Acute and Chronic Management in Chinese Adult Cardiac Surgical Patients | Biotech Hunter | Biotech Hunter